EFFECTS OF VACCINATION WITH T-CELL RECEPTOR-PEPTIDES - EPITOPE SWITCHING TO A POSSIBLE DISEASE-PROTECTIVE DETERMINANT OF MYELIN BASIC-PROTEIN THAT IS CROSS-REACTIVE WITH A TCR BV PEPTIDE
Aa. Vandenbark et al., EFFECTS OF VACCINATION WITH T-CELL RECEPTOR-PEPTIDES - EPITOPE SWITCHING TO A POSSIBLE DISEASE-PROTECTIVE DETERMINANT OF MYELIN BASIC-PROTEIN THAT IS CROSS-REACTIVE WITH A TCR BV PEPTIDE, Immunology and cell biology, 76(1), 1998, pp. 83-90
Immunization of Lewis rats with guinea-pig myelin basic protein (Gp-MB
P) induced T cell responses to primary and secondary encephalitogenic
determinants, as well as to a third non-encephalitogenic epitope, resi
dues 55-69. This sequence is of interest due to its protective activit
y against experimental autoimmune encephalomyelitis. Protection involv
ed induction of MBP-55-69-specific T cells expressing cross-reactive T
CR BV8S6 genes that activated regulatory T cells specific for TCR BV8S
2 determinants expressed on encephalitogenic T cells. We here present
and discuss new evidence suggesting a possible immunological crossreac
tivity between the protective Gp-MBP-55-69 peptide and the regulatory
BV8S2-39-59 peptide. This crossreactivity, which may also occur betwee
n the human MBP-55-74 peptide and the BV12S2-38-58 sequence, has poten
tially important implications for human diseases such as multiple scle
rosis.